病毒学报

参考文献

[1]Lindner J.Modrow S.Human bocavirus—a novel parvovirus to infect humans[J].Intervirology,2008,51(2): 116-122.

[2]Jones M S,Kapoor A.Lukashov V V,et al.New DNA viruses identified in patients with acute viral infection syndrome[J].J Virol,2005,79(13):8230-8236.

[3]Brown K E.The expanding range of parvoviruses which infect humans[J].Rev Med Virol,2010,20(4):231-244.

[4]Anderson M J,Jones S E,Fisher-Hoch S P,et al.Human parvovirus,the cause of erythema infectiosum(fifth disease) [J].Lancet,1983,1(8338):1378.

[5]Matsumura M.Parvovirus-associated arthritis[J].Am J Med,2001,111(3):241.

[6]Serjeant G R.Topley J M,Mason K,et al.Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus -like agent[J].Lancet,1981,2(8247):595-597.

[7]Young N S,Brown K E.Parvovirus B19[J].N Engl J Med,2004,350(6):586-597.

[8]Lamont R F,Sobel J D.Vaisbuch E,et al.Parvovirus B19 infection in human pregnancy[J].Bjog,2011,118 (2):175-186.

[9]Alvarez-Lafuente R,Fernandez-Gutierrez B.Jover JA,et al.Human parvovirus B19,varicella zoster virus,and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis:analysis with quantitative real time polymerase chain reaction[J].Ann Rheum Dis,2005,64(5):780-782.

[10]Aslanidis S,Pyrpasopoulou A,Kontotasios K,et al. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway[J].Eur J Intern Med,2008,9(5):314-318.

[11]Lunardi CTinazzi E,Bason C,et al.Human parvovirus B19 infection and autoimmunity[J].Autoimmun Rev, 2008,8(2):116-120.

[12]Servant A.Laperche S,Lallemand F.Genetic diversity within human erythroviruses:identification of three genotypes[J].J Virol,2002,76(18):9124-9134.

[13]Hubsche n J M.Mihneva Z,Mentis A F,et al.Phyloge- netic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b[J]. J Clin Microbiol,2009,7(11):3735-3738.

[14]Ke L,He M,Li C,et al.The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers[J].Transfusion,2011,51 (8):1-10.

[15]Ekman A.Hokynar K.Kakkola L,et al.Biological and immunological relations among human parvovirus B19 genotypes 1 to 3[J].J Virolology,2007,81(13):6927- 6935.

[16]DeissV,Tratschin J D,WeitzM,et al.Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini[J].Virology,1990,175(1): 247-254.

[17]MMWR Morb,Mortal Wkly Rep.Risks associated with human parvovirus B19 infection[J].Centers for Disease Control(CDC),1989,38(6):81-88,93-97.

[18]Pringle C R.Virus taxonomy update.The international committee on taxonomy of viruses.Taxonomic decisions ratified at the plenary meeting of the ICTV at the 9th internation Congress of Virology held in Glasgow on the 10th of August[J].Arch Virol,1993,133(3- 4):491-495.

[19]Guan W,Wong S,Zhi N,Qiu J.The genome of human parvovirus B19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus[J].J Virol,2009,83(18):9541-9553.

[20]Pillet S,Le Guyader N,Hofer T,et al.Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells[J].Virology,2004,327(1):1-7.

[21]Geoffroy M CSalvetti A.Helper functions required for wild type and recombinant adeno-associated virus growth[J].Curr Gene Ther,2005,5(3):265-271.

[22]Chen Z,Guan W,Cheng F.Chen A Y,Qiu J.Molecular characterization of human parvovirus B19 genotypes 2 and 3[J].Virology,2009,394(2):276-285.

[23]Guan W,Cheng F,Yoto Y,et al.Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome[J].J Virol,2008,82(20):9951-9963.

[24]Zhi N,Mills I P,Lu J,et al.Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NSl,VPl,and the 11- kilodalton protein in virus replication and infectivity [J].J Virol,2006,80(12):5941-5950.

[25]Chen A Y,Zhang E Y,Guan W.et al.The small 11 kDa ??nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells[J].Blood, 2010,115(5):1070-1080.

[26]Morita E.Tada K,Chisaka H,et al.Human parvovirus B19 induces cellcycle arrest at G(2) phase with accumulation ofmitotic cyclins[J],J Virol,2001,75(16): 7555-7563.

[27]Morita E,Nakashima A.Asao H,et al.Human parvovirus B19 nonstructural protein(NS1) induces cell cycle arrest at G(l) phase[J].J Virol,2003,77(5):2915- 2921.

[28]Sol N,Le Junter J,Vassias I,et al.Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19[J].J Virol,1999,73(10):8762- 8770.

[29]Morey A L,Keeling J W,Porter H J,et al.Clinical and histopathological features of parvovirus B19 infection in the human fetus[J].Br J Obstet Gynaecol,1992,99 (7):566-574.

[30]Kajigaya S,Fujii H,Field A,et al.Immunogenically similar to native virions[J].Proc Natl Acad Sci U S A, 1991,88(11):4646-4650.

[31]Zhi N,Wan Z,Liu X,et al.Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells[J].J Virol,2010,84 (24):13059-13062.

[32]Saikawa T.Anderson S,Momoeda M,et al.Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions[J].J Virol,1993, 67(6):3004-3009.

[33]Zuffi E.Manaresi E,Gallinella G,et al.Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans[J].Viral Immunol,2001,14(2):151- 158.

[34]Kurtzman G J,Cohen B J,Field A M,et al.Immune response to B19 parvovirus and an antibody defect in persistent viral infection[J].J Clin Invest,1989,84(4): 1114-1123.

[35]Filippone C,Zhi N,Wong S,et al.VPlu phospholipase activity is critical for infectivity of full-length,B19 genomic clones[J].Virology,2008,374(2):444-452.

[36]Lehmann H W,von Landenberg P.Modrow S.Parvovirus B19 infection and autoimmune disease[J].Autoimmun Rev,2003,2(4):218-223.

[37]Tzang B S.Tsay G J,Lee Y J,et al.The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production[J]. Clin Chim Acta,2007,378(1-2):59-65.

[38]Takahashi T,Ozawa K.Takahashi K,et al.,Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation[J].Blood,1990,75 (3):603-610.

[39]Brown K E,Anderson S M,Young N S,Erythrocyte P antigen:cellular receptor for B19 parvovirus[J].Science, 1993,262(5130):114-117.

[40]Munakata Y,Saito-Ito T,Kumura-Ishii K,et al.Ku80 autoantigen as a cellular coreceptor for human parvoviru s B19 infection[J].Blood,2005,106(10):3449- 3456.

[41]Wong S,Zhi N,Filippone C,et al.Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication[J].J Virol,2008,82 (5):2470-2476.

[42]Bonsch CZuercher CLieby P,et al.The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization[J].J Virol, 2010,84(22):11737-11746.

[43]Guan W,Cheng F,Yoto Y,et al.Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome[J].J Virol,2008,82(20):9951-9963.

[44]Ozawa K.Kurtzman G,Young N.Productive infection by B19 parvovirus of human erythroid bone marrow cells invitro[J].Blood,1987,70(2):384-391.

[45]Ozawa K.Kurtzman G,Young N.Replication of the B19 parvovirus in human bone marrow cell culture[J]. Science,1986,233(4766):883-886.

[46]Srivastava A,Lu L.Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow[J].J Virol,1988,62(8): 3059-3063.

[47]Takahashi T.Ozawa K,Takahashi K,et al.DNA replication of parvovirus B 19 in a human erythroid leukemia cell line(JK-1) in vitro[J].Arch Virol,1993,131 (1-2):201-208.

[48]Miyagawa E.Yoshida T,Takahashi H,et al.Infection of the erythroid cell line,KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity [J].J Virol Methods,1999,83(1-2):45-54.

[49]Munshi N C,Zhou S,Woody M J,et al.Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02[J].J Virol,1993,67(1):562- 566.

[50]Shimomura S,Komatsu N,Frickhofen N,et al.First continuous propagation of B19 parvovirus in a cell line [J].Blood,1992,79(1):18-24.

[51]Wong S,Brown K E.Development of an improved method of detection of infectious parvovirus B19[J].J Clin Virol,2006,35(4):407-413.

[52]Shimomura S,Wong S,Brown K E,et al.Early and late gene expression in UT-7 cells infected with B19 parvovirus [J].Virology,1993,194(1):149-156.

[53]Filippone CFranssila R,Kumar A,et al.Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection:molecular characteristics and functional competence[J].PLoS One,2010,5(3): 1-8.

[54]Chen A Y,Guan W,Lou S,et al.Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells[J].J Virol,2010,84 (23):12385-12396.

[55]Chen A Y,Kleiboeker S,Qiu J.Productive Parvovirus B19 Infection of Primary Human Erythroid Progenitor Cells at Hypoxia Is Regulated by STAT5A and MEK Signaling but not HIFα[J].PLoS Pathog.2011,7(6): 1-17.